Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:SWAV

Shockwave Medical (SWAV) Stock Price, News & Analysis

Shockwave Medical logo

About Shockwave Medical Stock (NASDAQ:SWAV)

Advanced Chart
Remove Ads

Key Stats

Today's Range
$334.75
$334.75
50-Day Range
$328.87
$334.83
52-Week Range
$157.00
$334.90
Volume
N/A
Average Volume
968,088 shs
Market Capitalization
$12.57 billion
P/E Ratio
78.21
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Shockwave Medical, Inc., a medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters used in IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter used for IVL System in large diameter vessels. It also provides product for the treatment of coronary artery disease, such as C2 IVL catheter and C2+IVL catheter that are two-emitter catheters for use in IVL system; and Reducer, a device to treat refractory angina. In addition, the company develops COSIRA-II trial; shockwave C2 Aero, a coronary IVL catheter; shockwave javelin coronary, a non-balloon-based catheter platform to treat of tight, difficult-to-cross coronary lesions; shockwave L6; shockwave E8 catheter, to target long peripheral artery lesions; shockwave javelin peripheral, a non-balloon-based catheter platform, to treat tight, difficult-to-cross peripheral lesions. Further, it offers shockwave carotid IVL, a purpose-built IVL System to treat calcified carotid artery lesions; and Shockwave Crescendo, a platform developed to treat calcified, stenotic heart valves. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.

Remove Ads
Receive SWAV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Shockwave Medical and its competitors with MarketBeat's FREE daily newsletter.

SWAV Stock News Headlines

**Breaking NEWS* This Company Starts To Rally As it Reduces $20 Million in Debt
**Breaking NEWS* This Company Starts To Rally As it Reduces $20 Million in Debt Discover why Notable Names like Cisco, Hewlett Packard and New York Life are Choosing to Do Business with this Growing Marketing Tech Company
GRPM: Why This Mid-Cap GARP ETF Deserves An Upgrade
See More Headlines

SWAV Stock Analysis - Frequently Asked Questions

Shockwave Medical, Inc. (NASDAQ:SWAV) released its earnings results on Monday, May, 6th. The company reported $1.44 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.99 by $0.45. The company's revenue for the quarter was up 35.8% on a year-over-year basis.

Shockwave Medical (SWAV) raised $75 million in an initial public offering (IPO) on Thursday, March 7th 2019. The company issued 5,000,000 shares at $14.00-$16.00 per share. Morgan Stanley and BofA Merrill Lynch acted as the underwriters for the IPO and Wells Fargo Securities and Canaccord Genuity were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Shockwave Medical investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Broadcom (AVGO), Arista Networks (ANET), ServiceNow (NOW) and CrowdStrike (CRWD).

Company Calendar

Last Earnings
5/06/2024
Today
4/08/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:SWAV
Fax
N/A
Employees
1,468
Year Founded
N/A

Profitability

Trailing P/E Ratio
78.21
Forward P/E Ratio
66.29
P/E Growth
2.43
Net Income
$147.28 million
Pretax Margin
23.29%

Debt

Sales & Book Value

Annual Sales
$787.97 million
Cash Flow
$4.31 per share
Price / Cash Flow
77.61
Book Value
$20.02 per share
Price / Book
16.72

Miscellaneous

Free Float
36,268,000
Market Cap
$12.57 billion
Optionable
Optionable
Beta
0.88
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NASDAQ:SWAV) was last updated on 4/8/2025 by MarketBeat.com Staff
From Our Partners